Danaher Corporation $DHR Shares Sold by Union Bancaire Privee UBP SA

Union Bancaire Privee UBP SA lessened its stake in shares of Danaher Corporation (NYSE:DHR) by 98.8% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 3,694 shares of the conglomerate’s stock after selling 305,858 shares during the quarter. Union Bancaire Privee UBP SA’s holdings in Danaher were worth $730,000 at the end of the most recent reporting period.

A number of other large investors have also recently added to or reduced their stakes in the business. NBC Securities Inc. acquired a new position in Danaher in the 1st quarter worth approximately $176,000. Affiance Financial LLC lifted its position in Danaher by 54.6% in the 1st quarter. Affiance Financial LLC now owns 1,136 shares of the conglomerate’s stock worth $233,000 after buying an additional 401 shares in the last quarter. Merit Financial Group LLC lifted its position in Danaher by 44.8% in the 1st quarter. Merit Financial Group LLC now owns 14,555 shares of the conglomerate’s stock worth $2,984,000 after buying an additional 4,505 shares in the last quarter. ST Germain D J Co. Inc. lifted its position in Danaher by 18.0% in the 1st quarter. ST Germain D J Co. Inc. now owns 4,197 shares of the conglomerate’s stock worth $860,000 after buying an additional 639 shares in the last quarter. Finally, Capital Asset Advisory Services LLC lifted its position in Danaher by 6.7% in the 1st quarter. Capital Asset Advisory Services LLC now owns 11,709 shares of the conglomerate’s stock worth $2,402,000 after buying an additional 736 shares in the last quarter. 79.05% of the stock is currently owned by institutional investors.

Danaher Stock Performance

Shares of DHR opened at $198.05 on Wednesday. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.62 and a quick ratio of 1.22. The company has a market capitalization of $141.82 billion, a PE ratio of 42.14, a price-to-earnings-growth ratio of 2.65 and a beta of 0.75. The company’s fifty day moving average price is $199.55 and its 200 day moving average price is $197.31. Danaher Corporation has a one year low of $171.00 and a one year high of $279.41.

Danaher (NYSE:DHR) last posted its quarterly earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.64 by $0.16. The company had revenue of $5.94 billion for the quarter, compared to analyst estimates of $5.83 billion. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The business’s quarterly revenue was up 3.4% on a year-over-year basis. During the same period last year, the business posted $1.72 EPS. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. As a group, analysts expect that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be given a $0.32 dividend. This represents a $1.28 annualized dividend and a yield of 0.6%. The ex-dividend date is Friday, September 26th. Danaher’s dividend payout ratio (DPR) is currently 27.23%.

Analysts Set New Price Targets

DHR has been the subject of a number of research analyst reports. Deutsche Bank Aktiengesellschaft cut their target price on shares of Danaher from $240.00 to $235.00 in a research report on Thursday, June 5th. Royal Bank Of Canada set a $241.00 price target on shares of Danaher in a report on Tuesday, September 2nd. Barclays restated an “overweight” rating and set a $225.00 price target (up previously from $215.00) on shares of Danaher in a report on Tuesday, June 24th. Evercore ISI cut their price target on shares of Danaher from $230.00 to $226.00 and set an “outperform” rating on the stock in a report on Tuesday, July 8th. Finally, Wall Street Zen upgraded shares of Danaher from a “hold” rating to a “buy” rating in a report on Friday, June 27th. Seventeen investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat, Danaher currently has an average rating of “Moderate Buy” and a consensus price target of $245.91.

Insider Transactions at Danaher

In other Danaher news, Director Teri List sold 2,778 shares of the firm’s stock in a transaction on Friday, August 22nd. The shares were sold at an average price of $211.06, for a total value of $586,324.68. Following the sale, the director directly owned 20,751 shares in the company, valued at $4,379,706.06. This trade represents a 11.81% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. 11.20% of the stock is owned by corporate insiders.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.